Agios Pharmaceuticals in the sale of its commercial, clinical and research-stage oncology portfolio to Servier for $2.0 billion

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.